Predictive Oncology Inc. Quarterly Depreciation in USD from Q1 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Predictive Oncology Inc. quarterly/annual Depreciation history and growth rate from Q1 2011 to Q2 2024.
  • Predictive Oncology Inc. Depreciation for the quarter ending June 30, 2024 was $157K, a 9.13% decline year-over-year.
  • Predictive Oncology Inc. Depreciation for the twelve months ending June 30, 2024 was $621K, a 27.8% decline year-over-year.
  • Predictive Oncology Inc. annual Depreciation for 2023 was $712K, a 20.8% decline from 2022.
  • Predictive Oncology Inc. annual Depreciation for 2022 was $898K, a 7% decline from 2021.
  • Predictive Oncology Inc. annual Depreciation for 2021 was $966K, a 35.8% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $621K $157K -$15.8K -9.13% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $636K $156K -$75.5K -32.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $712K $151K -$77.2K -33.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $789K $156K -$71K -31.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $860K $173K -$49.4K -22.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $909K $231K +$11.1K +5.05% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $898K $229K -$16.6K -6.75% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $915K $227K -$10.6K -4.46% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $926K $222K -$21.6K -8.85% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $947K $220K -$18.9K -7.89% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $966K $245K +$19.7K +8.76% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-21
Q3 2021 $946K $238K +$1.14K +0.48% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $945K $244K +$125K +105% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $820K $239K +$109K +83.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $711K $225K +$95.3K +73.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $616K $237K +$106K +80.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $510K $119K -$12.4K -9.47% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $523K $130K +$108K +494% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $414K $130K +$105K +409% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-15
Q3 2019 $310K $131K +$105K +401% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $205K $131K +$113K +598% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $92.4K $21.9K +$7.39K +51% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-08
Q4 2018 $85K $25.6K +$11.4K +81.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-01
Q3 2018 $73.5K $26.1K +$11.6K +79.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-15
Q2 2018 $62K $18.8K +$4.31K +29.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-19
Q1 2018 $57.7K $14.5K -$1.19K -7.58% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $58.9K $14.1K -$2.94K -17.3% Oct 1, 2017 Dec 31, 2017 10-K/A 2019-04-02
Q3 2017 $61.8K $14.6K -$3.22K -18.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $65K $14.5K -$4.69K -24.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $69.7K $15.7K -$3.52K -18.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $73.2K $17K Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 $17.8K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $19.2K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $19.2K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q1 2014 $9.39K +$9.07K +2918% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-15
Q1 2013 $311 +$164 Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q1 2012 $147* -$460 Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q1 2011 $607 Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.